ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NHC vs MD // PIOTROSKI F-SCORE QUALITY

National HealthCare Corporation (NYSE) VS. Pediatrix Medical Group Inc. (NYSE) • 15-METRIC TALLY: NHC 3 — MD 5
▲ PIOTROSKI F-SCORE QUALITY LEADER: NHC
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NHC VS. MD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NHC MD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.10% 33.60% -23.50 MD /roic <GO>
EV/EBITDA & P/E Valuation 20.5x 9.6x +10.90 MD /valuation <GO>
Free Cash Flow Yield 4.47% 11.43% -6.96 MD /fcf-yield <GO>
Operating Margin 8.50% — — TIE /operating-margins <GO>
Net Profit Margin 7.90% — — TIE /net-margins <GO>
Revenue Growth (YoY) 16.10% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 1.16% 0.00% +1.16 NHC /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.61 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 8/9 6/9 +2.00 NHC /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 35.1 71.7 -36.57 MD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 23.3x 13.3x +10.00 MD /forward-pe <GO>
Enterprise Scale & Market Cap $3.32B $2.37B $951.8M NHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NHC REV MD REV NHC GROSS % MD GROSS % NHC FCF MD FCF
FY 2025 $1.52B $0 — — $148.6M $271.1M
FY 2024 $1.31B $0 — — $79.7M $206.6M
FY 2023 $1.14B $0 — — $111.2M $137.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NHC // BETA —
MD // BETA —